New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Psyence Biomedical Ltd.

PBM

Healthcare Biotechnology

2.97 0.11 +3.85%

After hours trading: 3.01, up 1.35%, last trade Fri 4:09pm Eastern.

Market cap
$10.9M
P/E
0.1×
Fwd P/E
—
Dividend yield
—
F-score
n/a
ROIC
—
Net debt / EBITDA
1.2×
Payout ratio
—
Sep '25 Sep '24 Mar '24 Sep '23 Older periods
ROE
— — — 1.55%

+7 more TTM periods

ROA
— — — 1.45%
Return on Tangible Assets
— — — (11.57%)
Free Cash Flow per Share
(34.08) (1,125.07) — (0.32)
Free Cash Flow
(8.08) (6.30) (5.33) (2.48)
Other line items
Cash ROIC
(42.37%) (891.15%) 52.25% (2,807.26%)
Operating CF/Net income
— — — (1.34)
Operating CF per Share
(34.08) (1,125.07) — (0.32)
Capex per Share
0.00 0.00 — 0.00

Fold the line items

Columns are period end dates